BiochemProbe — Life Science Research Reagents

Oditrasertib free base · Synonyms: DNL788 | SAR443820

Oditrasertib is an orally active, BBB-penatrable and selective reversible inhibitor of RIPK1.

For research use only. Not for human or veterinary use.

Purity >98% Stock Inquire

Oditrasertib structure

CAS No.: 2252271-93-3

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
50 mg USD 420.00 BP-00101-50mg In stock Get quote
100 mg USD 578.00 BP-00101-100mg In stock Get quote
250 mg USD 885.00 BP-00101-250mg In stock Get quote
500 mg USD 1,195.00 BP-00101-500mg In stock Get quote
1 g USD 1,650.00 BP-00101-1g In stock Get quote

Need another size or custom synthesis? Request a quote.

Description

Oditrasertib (SAR443820) is an orally active, BBB-penatrable and selective reversible inhibitor of RIPK1. Oditrasertib can be used in the research of chronic inflammatory central nervous system diseases, such as amyotrophic lateral sclerosis and multiple sclerosis.

Biological activity

In Vitro Oditrasertib has a 50% inhibitory concentration of 3.16 nM in human PBMCs and 1.6 nM in iPSC-derived microglia.

Specifications

MW (average)
295.2846
Formula
C14H15F2N3O2
CAS No.
2252271-93-3
Physical state
Solid
Color
white to off-white
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder 4℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO

References

[1]. Fidalgo JDV, et al. Preparation of substituted oxazepines and related compounds as RIPK1 inhibitors and uses thereof. WO2018213632A1. 2018-11-22.
[2]. Hincelin-Mery A, et al. Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants. Clin Transl Sci. 2024 Jan;17(1):e13690.
[3]. Montalban X, et al. Effect of RIPK1 inhibitor, SAR443820, on serum neurofilament light levels in patients with multiple sclerosis: a phase 2 trial design (P6-3.011)[J]. Neurology, 2023, 100(17_supplement_2): 2178.

Same target

Search RIP kinase

Same research area

Search Neurological Disease

Recently viewed